Literature DB >> 8960835

Altered properties of the fibrin gel structure in patients with IDDM.

G Jörneskog1, N Egberg, B Fagrell, K Fatah, B Hessel, H Johnsson, K Brismar, M Blombäck.   

Abstract

High plasma fibrinogen levels are associated with vascular complications in the general population. Fibrin, the structural element in a clot, is derived from fibrinogen by activation of thrombin. An abnormal fibrin gel structure has been demonstrated in patients with myocardial infarction and in diabetic patients during poor metabolic control. In the present study the properties of fibrin gel structure were investigated in 20 patients with insulin-dependent diabetes mellitus (IDDM): 10 patients without (age: 30 +/- 8; diabetes duration: 7 +/- 6 years), and 10 patients (age: 44 +/- 7; diabetes duration: 27 +/- 9 years) with microangiopathy. Fifteen healthy subjects served as controls (age: 40 +/- 8 years). The glycosylated haemoglobin level (HbA1c) was elevated (p < 0.001) in the patients: 6.5 +/- 1.5% in diabetic patients without, and 7.1 +/- 1.0% in diabetic patients with microangiopathy. C-reactive protein and plasma fibrinogen were similar as compared to healthy control subjects. The properties of the fibrin gel structure; i.e. the permeability coefficient (Ks) and the fibre mass length ratio (mu) formed in recalcified plasma on addition of thrombin were investigated. Ks was decreased in the diabetic patients, with (6.5 +/- 2.0 cm2; p < 0.01) and without microangiopathy (6.5 +/- 2.7 cm2; p < 0.05), as compared to healthy subjects (10.0 +/- 3.4 cm2), while mu was not significantly (p = 0.14) altered. The results indicate a lower fibrin gel porosity in patients with IDDM, despite normal plasma fibrinogen and irrespective of microangiopathy. The abnormal fibrin gel structure may be due to an increased glycosylation of the fibrin (-ogen) molecule caused by long-term hyperglycaemia and may be of importance for the development of angiopathy in diabetic patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8960835     DOI: 10.1007/s001250050607

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  16 in total

1.  The influence of type 2 diabetes on fibrin structure and function.

Authors:  E J Dunn; R A S Ariëns; P J Grant
Journal:  Diabetologia       Date:  2005-04-29       Impact factor: 10.122

2.  FXIII-A Leu34 genetic variant in premature coronary artery disease: a genotype--phenotype case control study.

Authors:  Johanne Silvain; Ana Pena; Jean-Baptiste Vignalou; Jean-Sébastien Hulot; Sophie Galier; Guillaume Cayla; Anne Bellemain-Appaix; Olivier Barthélémy; Farzin Beygui; Claire Bal-dit-Sollier; Ludovic Drouet; John W Weisel; Gilles Montalescot; Jean-Phillippe Collet
Journal:  Thromb Haemost       Date:  2011-07-28       Impact factor: 5.249

3.  Experimental and imaging techniques for examining fibrin clot structures in normal and diseased states.

Authors:  Natalie K Fan; Philip M Keegan; Manu O Platt; Rodney D Averett
Journal:  J Vis Exp       Date:  2015-04-01       Impact factor: 1.355

4.  Molecular mechanisms involved in the resistance of fibrin to clot lysis by plasmin in subjects with type 2 diabetes mellitus.

Authors:  E J Dunn; H Philippou; R A S Ariëns; P J Grant
Journal:  Diabetologia       Date:  2006-03-16       Impact factor: 10.122

Review 5.  Diabetes and cardiovascular disease: pathophysiology of a life-threatening epidemic.

Authors:  R J King; P J Grant
Journal:  Herz       Date:  2016-05       Impact factor: 1.443

6.  Glycaemic control improves fibrin network characteristics in type 2 diabetes - a purified fibrinogen model.

Authors:  Marlien Pieters; Namukolo Covic; Francois H van der Westhuizen; Chandrasekaran Nagaswami; Yelena Baras; Du Toit Loots; Johann C Jerling; Dale Elgar; Kathryn S Edmondson; Danie G van Zyl; Paul Rheeder; John W Weisel
Journal:  Thromb Haemost       Date:  2008-04       Impact factor: 5.249

7.  Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice.

Authors:  Kellie R Machlus; Jessica C Cardenas; Frank C Church; Alisa S Wolberg
Journal:  Blood       Date:  2011-02-25       Impact factor: 22.113

8.  High-dose aspirin is required to influence plasma fibrin network structure in patients with type 1 diabetes.

Authors:  Sara Tehrani; Aleksandra Antovic; Fariborz Mobarrez; Koteiba Mageed; Per-Eric Lins; Ulf Adamson; Håkan N Wallén; Gun Jörneskog
Journal:  Diabetes Care       Date:  2011-12-06       Impact factor: 19.112

9.  A novel mechanism for hypofibrinolysis in diabetes: the role of complement C3.

Authors:  K Hess; S H Alzahrani; M Mathai; V Schroeder; A M Carter; G Howell; T Koko; M W J Strachan; J F Price; K A Smith; P J Grant; R A Ajjan
Journal:  Diabetologia       Date:  2011-09-15       Impact factor: 10.122

Review 10.  Interplay between ultrastructural findings and atherothrombotic complications in type 2 diabetes mellitus.

Authors:  Prashilla Soma; Etheresia Pretorius
Journal:  Cardiovasc Diabetol       Date:  2015-07-31       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.